83 FR 17827 - National Cancer Institute Cancellation Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 79 (April 24, 2018)

Page Range		17827-17828
FR Document		2018-08446

Federal Register, Volume 83 Issue 79 (Tuesday, April 24, 2018)

[Federal Register Volume 83, Number 79 (Tuesday, April 24, 2018)]
[Notices]
[Pages 17827-17828]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-08446]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute Cancellation Notice of Meeting

    Notice is hereby given of the cancellation of the National Cancer 
Institute Special Emphasis Panel, May 21, 2018, 5:00 p.m. to May 22, 
2018, 5:00 p.m., Bethesda North Marriott Hotel & Conference Center, 
5701 Marinelli Road, Linden Oak, Rockville, MD, 20852 which was 
published in the Federal Register on April 6, 2018, 83 FR 14869.

[[Page 17828]]

    This meeting has been cancelled due to an administrative oversight. 
A new meeting announcement will be posted soon. The meeting is closed 
to the public.

    Dated: April 18, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-08446 Filed 4-23-18; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 79 / Tuesday, April 24, 2018 / Notices 17827

childhood home visitation in the state are encouraged to work with nonprofit to require awardees to shift resources
including: the number and types of organizations that have received awards away from at-risk communities they
individuals and families who are to provide MIECHV services within the currently serve.
receiving services under such programs state and indicate whether they will Likely Respondents: MIECHV Program
or initiatives; the gaps in early submit their needs assessments directly Awardees that are states, territories,
childhood home visitation in the state; or through the nonprofit organization and, where applicable, nonprofit
and the extent to which such programs awardee. HRSA, states, and nonprofits organizations providing services within
or initiatives are meeting the needs of providing MIECHV services within states.
eligible families. states will use the information collected Burden Statement: Burden in this
(3) The state’s capacity for providing through the needs assessment update to context means the time expended by
substance abuse treatment and reaffirm the provision of MIECHV home persons to generate, maintain, retain,
counseling services to individuals and visiting services in at-risk communities. disclose, or provide the information
families in need of such treatment or The information will also be used to requested. This includes the time
services. support program planning, needed to review instructions and
The forthcoming SIR will provide improvement, and decision-making. The supporting materials; to collect and
further guidance to states in updating needs assessment update is not analyze data; engage with stakeholders
their statewide needs assessments and intended to disrupt current services or and coordinate with state level partners;
submitting the required information to negatively impact communities that and to draft and submit the report. The
HRSA. States that have elected not to have benefited from home visiting table below summarizes the total annual
apply for or be awarded MIECHV funds programs, nor is the intent of the update burden hours estimated for this SIR.

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of Average
Number of Total Total burden
Instrument responses per burden hours
respondents responses hours
respondent per response

Maternal, Infant, and Early Childhood Home Visiting Pro-
gram Statewide Needs Assessment Update ................... 56 1 56 95.57 5,352

Total .............................................................................. 56 ........................ 56 ........................ 5,352

HRSA specifically requests comments grant applications and the discussions Review/DERA, National Heart, Lung, and
on (1) the necessity and utility of the could disclose confidential trade secrets Blood Institute, 6701 Rockledge Drive, Room
proposed information collection for the or commercial property such as 7206, Bethesda, MD 20892–7924, 301–435–
proper performance of the agency’s patentable material, and personal 0303, ssehnert@nhlbi.nih.gov.
functions, (2) the accuracy of the information concerning individuals (Catalogue of Federal Domestic Assistance
estimated burden, (3) ways to enhance associated with the contract proposals Program Nos. 93.233, National Center for
the quality, utility, and clarity of the Sleep Disorders Research; 93.837, Heart and
and grant applications, the disclosure of
Vascular Diseases Research; 93.838, Lung
information to be collected, and (4) the which would constitute a clearly Diseases Research; 93.839, Blood Diseases
use of automated collection techniques unwarranted invasion of personal and Resources Research, National Institutes
or other forms of information privacy. of Health, HHS)
technology to minimize the information Name of Committee: National Heart, Lung,
collection burden. Dated: April 18, 2018.
and Blood Institute Special Emphasis Panel;
Michelle Trout,
Amy P. McNulty, National Gene Vector Biorepository Contract
Review. Program Analyst, Office of Federal Advisory
Acting Director, Division of the Executive Date: May 14, 2018. Committee Policy.
Secretariat. Time: 11:00 a.m. to 12:00 p.m. [FR Doc. 2018–08443 Filed 4–23–18; 8:45 am]
[FR Doc. 2018–08539 Filed 4–23–18; 8:45 am] Agenda: To review and evaluate contract BILLING CODE 4140–01–P
BILLING CODE 4165–15–P proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call). DEPARTMENT OF HEALTH AND
DEPARTMENT OF HEALTH AND HUMAN SERVICES
HUMAN SERVICES Contact Person: Charles Joyce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and National Institutes of Health
National Institutes of Health
Blood Institute, 6701 Rockledge Drive, Room
7196, Bethesda, MD 20892–7924, 301–827– National Cancer Institute Cancellation
National Heart, Lung, and Blood Notice of Meeting
7939, cjoyce@nhlbi.nih.gov.
Institute; Notice of Closed Meetings
Name of Committee: National Heart, Lung,
Pursuant to section 10(d) of the and Blood Institute Special Emphasis Panel; Notice is hereby given of the
Federal Advisory Committee Act, as Acute Lung Injury Program Project Review. cancellation of the National Cancer
amended, notice is hereby given of the Date: May 15, 2018. Institute Special Emphasis Panel, May
daltland on DSKBBV9HB2PROD with NOTICES

following meetings of the NHLBI Time: 9:00 a.m. to 12:00 p.m. 21, 2018, 5:00 p.m. to May 22, 2018,
Agenda: To review and evaluate grant 5:00 p.m., Bethesda North Marriott
Special Emphasis Panel. applications.
The meetings will be closed to the Place: Sheraton BWI (Baltimore), 1100 Old
Hotel & Conference Center, 5701
public in accordance with the Elkridge Landing Road, Baltimore, MD Marinelli Road, Linden Oak, Rockville,
provisions set forth in sections 21090. MD, 20852 which was published in the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Shelley S. Sehnert, Ph.D., Federal Register on April 6, 2018, 83 FR
as amended. The contract proposals and Scientific Review Officer, Office of Scientific 14869.

VerDate Sep<11>2014 17:03 Apr 23, 2018 Jkt 244001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\24APN1.SGM 24APN1

17828 Federal Register / Vol. 83, No. 79 / Tuesday, April 24, 2018 / Notices

This meeting has been cancelled due Drive, Room 7W254, Bethesda, MD 20892– DEPARTMENT OF HEALTH AND
to an administrative oversight. A new 9750, 240–276–7975, chufanee@mail.nih.gov. HUMAN SERVICES
meeting announcement will be posted Name of Committee: National Cancer
soon. The meeting is closed to the Institute Special Emphasis Panel; Innovative National Institutes of Health
public. Molecular Analysis Technologies.
Date: June 6, 2018. Eunice Kennedy Shriver National
Dated: April 18, 2018. Time: 8:00 a.m. to 5:00 p.m. Institute of Child Health & Human
Melanie J. Pantoja, Agenda: To review and evaluate grant Development (NICHD); Notice of
Program Analyst, Office of Federal Advisory applications. Meeting
Committee Policy. Place: Bethesda North Marriott Hotel, 5701
[FR Doc. 2018–08446 Filed 4–23–18; 8:45 am] Marinelli Road, North Bethesda, MD 20852. Pursuant to section 10(d) of the
Contact Person: Jun Fang, Ph.D., Scientific Federal Advisory Committee Act, as
BILLING CODE 4140–01–P
Review Officer, Research Technology and amended, notice is hereby given of a
Contract Review Branch, Division of meeting of the National Advisory Child
Extramural Activities, National Cancer Health and Human Development
DEPARTMENT OF HEALTH AND Institute, NIH, 9609 Medical Center Drive,
HUMAN SERVICES Council.
Room 7W246, Bethesda, MD 20892–9750,
The meeting will be open to the
240–276–5460, jfang@mail.nih.gov.
National Institutes of Health public as indicated below, with
Name of Committee: National Cancer attendance limited to space available. A
Institute Special Emphasis Panel NCI Clinical
National Cancer Institute Notice of and Translational Exploratory/
portion of this meeting will be closed to
Closed Meetings Developmental Studies and NCI, Small the public in accordance with the
Grants Program for Cancer Research (NCI provisions set forth in sections
Pursuant to section 10(d) of the Omnibus). 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Federal Advisory Committee Act, as Date: June 6, 2018. as amended for the review and
amended, notice is hereby given of the Time: 11:00 a.m. to 5:00 p.m. discussion of grant applications.
following meetings. Agenda: To review and evaluate grant Individuals who plan to attend and
The meetings will be closed to the applications. need special assistance, such as sign
public in accordance with the Place: National Cancer Institute, Shady language interpretation or other
Grove, 9609 Medical Center Drive, Room
provisions set forth in sections reasonable accommodations, should
7W242, Rockville, MD 20850, (Telephone
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Conference Call). notify the contact person listed below in
as amended. The grant applications and Contact Person: Zhiqiang Zou, MD, Ph.D., advance of the meeting.
the discussions could disclose Scientific Review Officer, Special Review Name of Committee: National Advisory
confidential trade secrets or commercial Branch, Division of Extramural Activities, Child Health and Human Development
property such as patentable material, National Cancer Institute, NIH, 9609 Medical Council.
and personal information concerning Center Drive, Room 7W242, Bethesda, MD Date: June 07, 2018.
individuals associated with grant 20892–9750, 240–276–6372, zouzhiq@ Open: June 07, 2018.
applications, the disclosure of which mail.nih.gov. Time: 8:00 a.m. to 12:30 p.m.
would constitute a clearly unwarranted Name of Committee: National Cancer Agenda: The agenda will include opening
Institute Initial Review Group Subcommittee remarks, administrative matters, Director’s
invasion of personal privacy. Report, Division of Extramural Research
F—Institutional Training and Education.
Name of Committee: National Cancer Date: June 12, 2018. Report and, other business of the Council.
Institute Special Emphasis Panel; Time: 12:30 p.m. to 5:00 p.m. Place: National Institutes of Health,
Partnerships in Cancer Research (P20) and Agenda: To review and evaluate grant Building 31, C-Wing, Conference Room 6,
Cancer Health Equity (U54). applications. 9000 Rockville Pike, Bethesda, MD 20892.
Date: May 21–22, 2018. Place: National Cancer Institute, Shady Closed: June 07, 2018.
Time: 5:00 p.m. to 5:00 p.m. Grove, 9609 Medical Center Drive, Room Time: 1:30 p.m. to Adjournment.
Agenda: To review and evaluate grant 7W624, Rockville, MD 20850, (Telephone Agenda: To review and evaluate grant
application. Conference Call). applications.
Place: Bethesda North Marriott Hotel & Contact Person: Timothy C. Meeker, MD, Place: National Institutes of Health,
Conference Center, 5701 Marinelli Road, Building 31, C-Wing, Conference Room 6,
Scientific Review Officer, Resources and
North Bethesda, MD 20852. 9000 Rockville Pike, Bethesda, MD 20892.
Training Review Branch, Division of
Contact Person: Clifford W. Schweinfest, Contact Person: Della Hann, Ph.D.,
Extramural Activities, National Cancer
MD, Scientific Review Officer, Special Director, Division of Extramural Research,
Institute, NIH, 9609 Medical Center Drive,
Review Branch, Division of Extramural Eunice Kenney Shriver National Institute of
Room 7W624, Bethesda, MD 20892–9750, Child Health and Human Development, NIH,
Activities, National Cancer Institute, NIH, 240–276–6464, meekert@mail.nih.gov.
9609 Medical Center Drive, Room 7W108, 6710 Rockledge Blvd., MSC 7002, Bethesda,
(Catalogue of Federal Domestic Assistance MD 20892, 301–496–8535.
Bethesda, MD 20892–9750, 240–276–6343, Program Nos. 93.392, Cancer Construction;
schweinfestcw@mail.nih.gov. Any interested person may file written
93.393, Cancer Cause and Prevention comments with the committee by forwarding
Name of Committee: National Cancer Research; 93.394, Cancer Detection and the statement to the contact person listed on
Institute Special Emphasis Panel; SEP–7: NCI Diagnosis Research; 93.395, Cancer this notice. The statement should include the
Clinical and Translational R21 and Omnibus Treatment Research; 93.396, Cancer Biology name, address, telephone number, and when
R03. Research; 93.397, Cancer Centers Support; applicable, the business or professional
Date: June 4–5, 2018. 93.398, Cancer Research Manpower; 93.399, affiliation of the interested person.
Time: 6:00 p.m. to 5:00 p.m. Cancer Control, National Institutes of Health, In the interest of security, NIH has
Agenda: To review and evaluate grant HHS) instituted stringent procedures for entrance
daltland on DSKBBV9HB2PROD with NOTICES

applications. onto the NIH campus. All visitor vehicles,
Place: Bethesda North Marriott Hotel, 5701 Dated: April 18, 2018. including taxis, hotel, and airport shuttles,
Marinelli Road, North Bethesda, MD 20852. Melanie J. Pantoja, will be inspected before being allowed on
Contact Person: Eduardo E. Chufan, Ph.D., campus. Visitors will be asked to show one
Program Analyst, Office of Federal Advisory
Scientific Review Officer, Research form of identification (for example, a
Committee Policy.
Technology and Contract Review Branch, government-issued photo ID, driver’s license,
Division of Extramural Activities, National [FR Doc. 2018–08445 Filed 4–23–18; 8:45 am] or passport) and to state the purpose of their
Cancer Institute, NIH, 9609 Medical Center BILLING CODE 4140–01–P visit.

VerDate Sep<11>2014 17:03 Apr 23, 2018 Jkt 244001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\24APN1.SGM 24APN1

Document Created: 2018-04-24 00:38:58
Document Modified: 2018-04-24 00:38:58

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		83 FR 17827